Association between cognitive impairment and guideline adherence for application of chemotherapy in older patients with breast cancer: Results from the prospective multicenter BRENDA II study.
Elena LeinertLukas SchwentnerMaria BlettnerAchim WöckelRicardo FelberbaumFelix FlockThorsten KühnMichael Dieter DenkingerWolfgang JanniRolf KreienbergSusanne Singernull nullPublished in: The breast journal (2019)
Almost one third of older patients with breast cancer are affected by cognitive impairment prior to adjuvant treatment. In these patients, cognitive impairment was associated with tumor board decision against chemotherapy in spite of a positive guideline recommendation.
Keyphrases
- cognitive impairment
- end stage renal disease
- newly diagnosed
- ejection fraction
- physical activity
- locally advanced
- chronic kidney disease
- community dwelling
- middle aged
- prognostic factors
- squamous cell carcinoma
- type diabetes
- radiation therapy
- decision making
- adipose tissue
- patient reported outcomes
- rectal cancer
- patient reported
- skeletal muscle
- chemotherapy induced
- double blind
- weight loss